# K121879: Vega Knee System

- Pathway: 510(k) (Special)
- Applicant: Aesculap Implant Systems
- Decided: Jul 27, 2012 after 29 days
- Product code: JWH (Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer)
- Device class: 2
- Regulation: 21 CFR 888.3560
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K101281 (2010). 1 ancestor in all.
14 later devices descend from it; 4 cite it directly.
0 of 16 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K101281: Vega Knee System, Aesculap Implant System, Inc. (2010) Summary page 1.

## Most influential descendants
- K152008: Physica PS Knee System (2015), 7 descendants of its own
- K193284: Physica LMC Knee System (2020), 6 descendants of its own
- K201084: Physica system (2020), 5 descendants of its own
- K140452: Vega Knee System (2014), 5 descendants of its own
- K143106: VEGA Knee System (2014), 4 descendants of its own

## Indications for use
The VEGA Knee System is indicated for use in reconstruction of the diseased knee joint caused by osteoarthritis, rheumatoid arthritis, post-traumatic arthritis, the need to revise failed arthroplasties or osteotomies where pain, deformity or dysfunction persist, and for patients suffering from correctable valgus or varus deformity and moderate flexion contracture. Posterior Stabilized (PS) components are also for absent or non-functioning posterior cruciate ligament and severe anteroposterior instability of the knee joint. The VEGA Knee System is designed for use with bone cement.

Source page: https://510kreport.com/device/K121879
Methodology: https://510kreport.com/methodology
